Design of Inhibitory Peptides Based on TRPM4-KCTD5 Interaction
Javiera Baeza1,2, Diego Maureira1, Mariela Gonzalez-Avendaño2
1Núcleo Interdisciplinario de Biología y Genética, Instituto de Ciencias Biomédicas, Facultad de Medicina, Universidad de Chile, Santiago8380453, Chile.
Abstract:
High expression of TRPM4 has been reported to be associated with pathologies that alter cytoskeletal rearrangement and cell migration, including fibrosis and metastatic cancer, across different cell lines. The KCTD5 protein was identified as a positive regulator of TRPM4, thereby increasing Ca2+ sensitivity. KCTD5 is involved in cell migration by regulating TRPM4. TRPM4 and KCTD5 expression levels are elevated in breast cancer with poor prognosis. Therefore, the TRPM4-KCTD5 interaction represents an attractive target for the development of peptides that modulate TRPM4 activity with therapeutic potential. Based on this premise, two peptides derived from the TRPM4-KCTD5 interface were designed in silico and evaluated using in vitro assays in HEK293, HEK293KCTD5-/-, and MDA-MB231 cells, including intracellular sodium recordings, patch clamp, cell invasion, and bimolecular fluorescent complementation (BiFC). In BiFC assays, a decrease in the fluorescence of TRPM4-KCTD5 complexes was observed upon treatment with the peptides TAT-TRPM4-HA or TAT-KCTD5-HA, indicating a loss of the TRPM4-KCTD5 interaction. A significant decrease in TRPM4-dependent Na+ influx and currents was observed in HEK293 cells treated with the peptides TAT-TRPM4-HA and TAT-KCTD5-HA compared to untreated controls. Furthermore, a significant decrease in cell invasion was observed in MDA-MB-231 cells treated with the TAT-TRPM4-HA peptide compared with controls. Overall, these experiments demonstrate that the in silico-designed peptides can inhibit the TRPM4-KCTD5 interaction and reduce MDA-MB-231 cell invasion, highlighting this protein interface as a promising therapeutic target for metastatic breast cancer.
Insights
Researchers designed peptides to block the TRPM4-KCTD5 interaction, a key driver in metastatic breast cancer. These peptides successfully reduced cancer cell invasion, offering a potential new therapeutic strategy.
Area of Science:
- Molecular Biology
- Cell Biology
- Oncology
Background:
- Transient Receptor Potential Melastatin 4 (TRPM4) channels are implicated in cytoskeletal rearrangement and cell migration, contributing to pathologies like fibrosis and metastatic cancer.
- KCTD5 acts as a positive regulator of TRPM4, enhancing its calcium (Ca2+) sensitivity and influencing cell migration.
- Elevated TRPM4 and KCTD5 expression correlates with poor prognosis in breast cancer, identifying their interaction as a potential therapeutic target.
Purpose of the Study:
- To design and evaluate peptides targeting the TRPM4-KCTD5 protein-protein interaction.
- To assess the therapeutic potential of these peptides in inhibiting TRPM4 activity and reducing cancer cell invasion.
Main Methods:
- In silico peptide design based on the TRPM4-KCTD5 interface.
- In vitro assays including bimolecular fluorescent complementation (BiFC), patch clamp electrophysiology, and intracellular sodium recordings.
- Cell invasion assays using MDA-MB-231 breast cancer cells.
Main Results:
- Designed peptides (TAT-TRPM4-HA, TAT-KCTD5-HA) disrupted the TRPM4-KCTD5 interaction, as shown by reduced BiFC signal.
- Peptide treatment significantly decreased TRPM4-dependent sodium (Na+) influx and ion channel currents in HEK293 cells.
- The TAT-TRPM4-HA peptide notably reduced cell invasion in MDA-MB-231 breast cancer cells.
Conclusions:
- The developed peptides effectively inhibit the TRPM4-KCTD5 interaction.
- Targeting the TRPM4-KCTD5 interface with peptides shows promise for reducing metastatic breast cancer cell invasion.
- The TRPM4-KCTD5 interaction represents a viable therapeutic target for metastatic breast cancer treatment.
More Related Videos
Related Concept Videos
Thermosensation
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Resting Membrane Potential
The Inside of a Neuron is More Negative
The membrane potential of a cell can be measured by inserting a microelectrode into a cell and comparing the charge to a reference electrode in the extracellular fluid. The...
Feedback Inhibition


